Loading...

IHH Healthcare to open USD93 mn hospital in Malaysia

Image

29-Oct-15 Malaysian healthcare provider IHH Healthcare Bhd is going to open its RM400 mn (USD93 mn) Gleneagles Medini Hospital in Nusajaya, Johor. The 300-bed tertiary hospital is IHH's 14th hospital in Malaysia, following the opening of Gleneagles Kota Kinabalu in May by Parkway Pantai, a wholly-owned subsidiary of IHH Healthcare. [image: The Star]

Read More

GE to pump up to USD1 bn into Indonesia

Image

27-Oct-15 GE will align with Indonesia's objective of providing universal healthcare by supporting the expansion of the country's primary healthcare ecosystem, including the development of up to 100 primary care clinics through technology and training innovations. Given the importance of healthcare for the country, GE relocated the headquarters of its healthcare business in ASEAN to Jakarta earlier this year. [image: GE]

Read More

UK and China agree GBP2 bn healthcare deals

Image

21-Oct-15 With a population of more than one billion and a rapidly developing economy, China is set to become the world’s fastest growing healthcare market. Today’s £2 billion trade package for UK exports in research, hospital construction, training, diagnostics and drug discovery shows the huge potential of UK/Chinese Life Science trade. [image: GOV.UK]

Read More

GSK joins UK China trade push

Image

21-Oct-15 GlaxoSmithKline's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly USD500 mn (GBP323 mn ) for bribing Chinese doctors. The group has since been rebuilding its position in China. [image: Reuters / Luke Macgregor]

Read More

AstraZeneca opens new manufacturing facility to support continued growth in Russia

Image

20-Oct-15 AstraZeneca announced a new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing facility in Russia. Four years on, the Company has invested USD224m. [image: AstraZeneca]

Read More
Share